IR-1061: Transforming Deep Tissue Biomedical Imaging with Near Infrared Fluorescent Dye

Principle and Setup: Why IR-1061 Leads in Near Infrared Imaging

The demand for high-contrast, deep-tissue visualization in biomedical research has led to the rise of near infrared (NIR) probes that emit beyond 1000 nm. IR-1061, a thiopyrilium-based organic dye supplied by APExBIO, exemplifies this next-generation approach, delivering robust NIR fluorescence for in vivo imaging where background autofluorescence is minimized and tissue penetration is maximized. With a molecular formula of C44H34BClF4S2 and a molecular weight of 749.13, IR-1061 is optimized for optical and molecular imaging workflows where deep, dynamic, and multiplexed observations are critical.

Unlike traditional visible-wavelength dyes, IR-1061’s emission in the OTN-NIR (over-thousand-nanometer near-infrared) window allows for signal detection several millimeters into biological tissue, according to a recent reference study and corroborated by practical imaging case studies. The dye’s hydrophobic and polar characteristics also make it ideal for encapsulation in polymeric nanoparticles, which further increases biocompatibility and probe stability for live animal experiments.

Step-by-Step Workflow: Preparation and Imaging Using IR-1061

IR-1061’s solid form and unique solubility profile (soluble in DMSO at ≥25.65 mg/mL; insoluble in ethanol and water) inform critical protocol choices. The following workflow is distilled from leading publications and supplier recommendations:

Protocol Parameters

• Stock Solution Preparation: Dissolve IR-1061 at 25.65–30 mg/mL in anhydrous DMSO. Vortex for 2 minutes and sonicate for 5 minutes to ensure homogenization.
• Nanoparticle Encapsulation: For polystyrene-based nanoparticles, load IR-1061 at a dye-to-polymer ratio of 1:40 by weight, with the swelling–diffusion process performed at 37°C for 4 hours (as optimized in the reference study).
• Storage Conditions: Store the dry dye at -20°C, desiccated and tightly sealed. Use freshly prepared DMSO solutions within 2 hours to maximize fluorescence and minimize degradation.
• In Vivo Imaging: Inject nanoparticle-encapsulated IR-1061 intravenously at a dose of 0.5–1.0 mg/kg mouse body weight, then image at 1060–1100 nm emission using a NIR-II imaging system, beginning 10–30 minutes post-injection for optimal circulation and tissue uptake.

Key Innovation from the Reference Study

The reference study unveiled a robust method for loading IR-1061 into polystyrene nanoparticles (PSt NPs) via a swelling–diffusion process, crucially tuning the nanoparticle core polarity to match the dye’s polarity. This prevents aggregation and fluorescence quenching—a common pitfall with hydrophobic NIR dyes. By adjusting the ratio of styrene to acrylic acid in the polymer, and precisely controlling DMSO concentration during dye loading, the researchers achieved nanoparticles with high emission intensity, remarkable dispersion stability under physiological conditions, and minimal leakage of encapsulated dye.

This methodology is highly relevant for researchers seeking to design stable, bright probes for dynamic live imaging in vivo. Covalent PEGylation of the nanoparticles, as implemented in the study, further improved blood circulation time and biocompatibility, demonstrating clear in vivo imaging of mouse tissues with minimal cytotoxicity.

Advanced Applications and Comparative Advantages

IR-1061’s performance is distinguished by several features:

• Deep Tissue Penetration: Its emission at >1000 nm enables imaging several millimeters deep, far surpassing most visible and first-window NIR dyes. This is validated in both the reference study and in additional workflow reports, which document high-contrast vascular and tumor imaging in small animal models.
• Ultra-Low Background: Imaging in the NIR-II window (1000–1700 nm) reduces tissue autofluorescence, yielding high signal-to-noise ratios—a critical advantage for sensitive detection and quantification in preclinical studies.
• Multiplexed and Longitudinal Imaging: IR-1061’s robust encapsulation in nanoparticles allows for repeated imaging sessions without significant signal decay or probe redistribution, as highlighted in complementary imaging guides.
• Customizable Probe Design: The swelling–diffusion encapsulation method supports integration with a variety of polymer matrices (e.g., polystyrene, poly(lactic acid)), as discussed in both the reference and the polymer-chirality study, which expands the probe's utility across different biomedical applications.

Troubleshooting and Optimization Tips

Maximizing IR-1061’s performance requires attention to several critical variables:

• Solubility Challenges: IR-1061 is a fluorescent dye soluble in DMSO but insoluble in ethanol and water. Always prepare fresh DMSO stock on the day of use, and avoid exposure to moisture, which can induce aggregation and quenching.
• Encapsulation Efficiency: Polarity mismatch between the dye and nanoparticle matrix leads to aggregation and emission loss. Adjust the acrylic acid content in polystyrene nanoparticles (5–10% by weight) to match IR-1061’s polarity, as detailed in the reference study.
• Dye Leakage and Stability: Encapsulation in micellar systems is susceptible to in vivo decomposition. Prefer robust polymer-based nanoparticles for long-term circulation and minimal dye leakage, a finding consistently reported in both foundational and comparative studies (see here).
• PEGylation for Biocompatibility: Surface modification with PEG (polyethylene glycol) significantly improves colloidal stability and reduces immune recognition, as experimentally validated in the reference study.
• Batch-to-Batch Consistency: Use HPLC and NMR to confirm purity and structure of each IR-1061 lot (as per APExBIO’s QC standards), and always verify fluorescence output using a standardized NIR-II calibration protocol.

If unexpected quenching or low signal is observed, re-examine the polarity match and DMSO content during the encapsulation step, and ensure that imaging is performed within the recommended post-injection window to capture peak circulation.

Connecting the Literature: Complementary and Extending Insights

The workflow described here draws upon and extends several key resources:

• IR-1061: Near Infrared Fluorescent Dye for Deep Tissue Imaging offers a practical overview of encapsulation options and multiplexed imaging, complementing the present guide’s focus on nanoparticle polarity optimization.
• IR-1061 Near Infrared Fluorescent Dye: Deep Tissue Imaging in Action provides stepwise experimental workflows and troubleshooting, extending the protocol suggestions found here to broader biomedical contexts.
• Enantiomeric Polymer Effects on IR-1061 Encapsulation for NIR-II Imaging explores how chiral polymer matrices influence stability and emission, expanding on the reference study’s findings by offering materials selection guidance for probe developers.

Together, these resources create a robust, evidence-based framework for deploying IR-1061 in a variety of advanced optical and molecular imaging workflows.

Future Outlook: From Preclinical Imaging to Next-Generation Probe Design

The synergy of IR-1061’s chemical properties and nanoparticle encapsulation strategies is ushering in a new era of in vivo NIR-II imaging. As shown in both the reference study and corroborative workflow reports, optimized probe design enables high-resolution, dynamic imaging of vascular and tumor structures with unparalleled clarity and stability. The translation of these methods promises to accelerate discovery in oncology, tissue engineering, and pharmacokinetics, while ongoing improvements in nanoparticle architecture and surface modification will further expand the toolkit for researchers.

Limitations remain, particularly regarding scale-up, regulatory approval, and long-term biocompatibility assessments. However, the protocol enhancements and troubleshooting insights summarized here, underpinned by rigorous evidence, position IR-1061—especially as supplied by APExBIO—as a cornerstone for next-generation deep tissue imaging in biomedical research.